Literature DB >> 12556654

The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs.

Trefor Morgan1, Adrianne Anderson.   

Abstract

Hypertension and arthritis are both common diseases in the older age group and require pharmacologic treatment. Nonsteroidal anti-inflammatory drugs (NSAIDs) alter renal function if given in high enough doses, reducing renal blood flow and the glomerular filtration rate and causing sodium retention. In salt sensitive subjects, this retention of sodium will cause blood pressure to rise. Salt sensitivity is more common in elderly patients, in diabetics, and in people with renal failure. When most antihypertensive drugs are used, people become salt sensitive, as shown by the additive effect of salt restriction or diuretics on blood pressure response. The responses to dihydropyridine and possibly other calcium channel blocking drugs are not affected to any major extent by sodium intake or by diuretics. Studies are described which indicate that indomethacin elevates blood pressure in elderly people treated with enalapril, but not in people whose blood pressure is controlled with amlodipine or felodipine. It is unclear whether the various NSAIDs have different effects on blood pressure. It is proposed that if the same analgesic effect is achieved with the same amount of cyclooxygenase inhibition, the response will be similar. Aspirin, used in a prophylactic dose, does not inhibit to this extent and does not elevate blood pressure. If elderly people require NSAIDs, it would appear that dihydropyridine calcium channel blocking drugs are more effective at lowering and maintaining blood pressure control and should be one of the drugs used. If patients are on other antihypertensive agents, it is important to monitor blood pressure when a NSAID is added to therapy. Copyright 2003 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12556654      PMCID: PMC8101828          DOI: 10.1111/j.1524-6175.2003.00514.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

1.  The antihypertensive actions of benzothiadiazines.

Authors:  B M WINER
Journal:  Circulation       Date:  1961-02       Impact factor: 29.690

2.  Effects of celecoxib and naproxen on renal function in the elderly.

Authors:  A Whelton; G Schulman; C Wallemark; E J Drower; P C Isakson; K M Verburg; G S Geis
Journal:  Arch Intern Med       Date:  2000-05-22

3.  Paradoxical effect of sodium restriction on blood pressure in people on slow-channel calcium blocking drugs.

Authors:  T Morgan; A Anderson; D Wilson; J Myers; J Murphy; C Nowson
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

4.  Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man.

Authors:  R V Patak; B K Mookerjee; C J Bentzel; P E Hysert; M Babej; J B Lee
Journal:  Prostaglandins       Date:  1975-10

5.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

Authors:  R C Harris; J A McKanna; Y Akai; H R Jacobson; R N Dubois; M D Breyer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs.

Authors:  J L Blackshear; M Davidman; M T Stillman
Journal:  Arch Intern Med       Date:  1983-06

7.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.

Authors:  J Watkins; E C Abbott; C N Hensby; J Webster; C T Dollery
Journal:  Br Med J       Date:  1980-09-13

8.  Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

Authors:  Y Zhang; A Shaffer; J Portanova; K Seibert; P C Isakson
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

9.  Indomethacin attenuates the hypotensive action of hydralazine.

Authors:  M P Cinquegrani; C S Liang
Journal:  Clin Pharmacol Ther       Date:  1986-05       Impact factor: 6.875

10.  The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide.

Authors:  J T Wright; J M McKenney; A M Lehany; D L Bryan; L W Cooper; C M Lambert
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

View more
  10 in total

1.  Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.

Authors:  María Esther Rubio-Ruiz; Israel Pérez-Torres; Eulises Diaz-Diaz; Natalia Pavón; Verónica Guarner-Lans
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 2.  Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease.

Authors:  Jerry Johnson; Joan Weinryb
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

3.  Perceived medication use challenges and coping strategies among medical outpatients in Nigeria.

Authors:  Kazeem B Yusuff
Journal:  Int J Clin Pharm       Date:  2012-10-11

Review 4.  Drug-Induced Hypertension: Focus on Mechanisms and Management.

Authors:  Alexandra R Lovell; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 5.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Possible role for brain prostanoid pathways in the development of angiotensin II-salt hypertension in rats.

Authors:  Ninitha Asirvatham-Jeyaraj; Gregory D Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-05-25       Impact factor: 3.619

7.  Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.

Authors:  Kathleen M Knights; Leanne K Winner; David J Elliot; Kushari Bowalgaha; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 8.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Authors:  Walter H Hörl
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-21

9.  Treatment with betablockers is associated with higher grey-scale median in carotid plaques.

Authors:  Giuseppe Asciutto; Nuno V Dias; Ana Persson; Jan Nilsson; Isabel Gonçalves
Journal:  BMC Cardiovasc Disord       Date:  2014-08-30       Impact factor: 2.298

10.  Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm.

Authors:  Unyime I Eshiet; Kazeem B Yusuff
Journal:  Pharm Pract (Granada)       Date:  2014-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.